Navigation Links
Halozyme Therapeutics Presents Pre-Clinical Studies of Systemic Delivery of Pegylated rHuPH20 Enyzme in Prostate Cancer Models at American Association for Cancer Research Conference
Date:4/15/2008

ry of findings is as follows:

-- Prostate carcinoma cells assembled large pericellular coats in vitro

that collapsed in the presence of the hyaluronidase enzyme, rHuPH20.

Similar pericellular matrices containing HA were also assembled in vivo

following inoculation of tumors around the bone in mice.

-- PEGrHuPH20 significantly reduced tumor IFP in a dose dependent fashion,

achieving more than 85% reduction in IFP following IV administration.

Peritumoral HA remained depleted over 3 days after a single dose of

enzyme.

-- Consistent with the histologic collapse of pericellular HA surrounding

the tumor cells, tumor water content significantly decreased over 3

days, consistent with changes detected in the tumor by MRI and IFP

monitoring.

-- Furthermore, a 3.5-fold selective increase in tumor vascular volume was

achieved within 8 hours post-dosing as a result of vascular

decompression of blood vessels within the tumor, which was confirmed by

histology and ultrasound.

"These findings represent significant advancements towards our goal of understanding the role of HA in the tumor microenvironment and mechanism of action of PEGrHuPH20" said Gregory Frost, PhD, Halozyme's Vice President and Chief Scientific Officer. "By selectively decompressing tumor vessels, we may significantly improve tumor exposure and responses to chemotherapy regimens. These findings have facilitated our efficacy studies in combination with selected chemotherapy agents, which will be presented later this year as part of our overall development strategy for this new compound."

About Halozyme Therapeutics, Inc.

Halozyme is a biopharmaceutical company developing and commercializing products targeting the extracellular matrix for the drug delivery, oncology and dermatology markets. The company's portfolio of products and product candidates is based
'/>"/>

SOURCE Halozyme Therapeutics, Inc.
Copyright©2008 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3 4

Related medicine technology :

1. Halozyme Therapeutics Announces Peer-Reviewed Publications of the INFUSE-LR Clinical Trial Results and Clinical Practice Experience With Hylenex
2. Halozyme Therapeutics Completes Enrollment in Chemophase Phase I/IIa Clinical Trial for Superficial Bladder Cancer
3. Nektar Therapeutics to Present Positive Data at Upcoming Medical and Scientific Meetings
4. Echo Therapeutics Announces Positive Results with the Prelude(TM) SkinPrep System, the Next-Generation Skin Permeation Medium for its Symphony(TM) Transdermal Continuous Glucose Monitoring System
5. Recent siRNA Research Publications Support Silence Therapeutics Combined Development Approach
6. European Regulatory Agency Accepts Cell Therapeutics, Inc.s Marketing Authorization Application for XYOTAX(TM) for Lung Cancer for Review
7. CV Therapeutics Anti-Ischemic Therapy Ranexa(R) Significantly Reduces Cardiac Chest Pain Symptoms and Recurrent Ischemia in MERLIN-TIMI 36 Patients With Angina
8. Michael J. Fox Foundation Commits up to $10 Million for Pre-Clinical Drug Development Under Therapeutics Development Initiative
9. Synvista Therapeutics Presents New Preclinical Data Demonstrating the Value of Haptoglobin Genotype Testing In Diabetes at ACC Scientific Sessions
10. Cell Therapeutics, Inc. (CTI) Announces Enrollment Complete in Phase III EXTEND (PIX301) Clinical Trial of Pixantrone in Patients With Second or Greater Relapse of Diffuse Large B Cell NHL
11. Dynamis Therapeutics, Inc. Discovers RAGE Inhibitor
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2013)... 2013  Aribex, Inc., manufacturer of the newly released ... new color option, black with gray trim, of the ... markets. The popular white with light blue trim Pro ... be available and both models can be purchased from ... http://photos.prnewswire.com/prnh/20130522/CL19573 ) "Dental offices are adding ...
(Date:5/22/2013)... , May 22, 2013 Attorney ... potential claims on behalf of purchasers of the ... "Company") (NasdaqGS: AMAG -News).  The investigation focuses on ... securities laws. On May 22, 2013, ... intraday trading after the company announced in regulatory ...
(Date:5/22/2013)... and CAESAREA, Israel , May 22, ... New clinical data presented from the DEFLECT-I study demonstrates ... reduces brain lesion volume during TAVR (Transcatheter Aortic Valve ... Keystone Heart Scientific Advisory Board announces consensus on the ... regarding the importance and need for cerebral protection during ...
Breaking Medicine Technology:Aribex Unveils New Color of NOMAD Pro 2 2Bronstein, Gewirtz & Grossman, LLC Announces Investigation of AMAG Pharmaceuticals, Inc. 2New Clinical Data Presented at EuroPCR Demonstrates that TriGuard Reduces Brain Lesion Volume during TAVR 2New Clinical Data Presented at EuroPCR Demonstrates that TriGuard Reduces Brain Lesion Volume during TAVR 3New Clinical Data Presented at EuroPCR Demonstrates that TriGuard Reduces Brain Lesion Volume during TAVR 4
(Date:5/23/2013)... Heights,OH (PRWEB) May 23, 2013 Angeline Jolie’s ... genetic study showing there was an 87% chance she would ... odds of getting breast cancer. Long term studies show American ... during their lifetime (1). , Among the things that ... alcohol (more than a drink a day) smoking, and avoiding ...
(Date:5/23/2013)... According to the Centers for Disease Control, heart ... America today and is the leading cause of death in ... in the United States each year of heart disease, translating ... to profile the status of the cardiovascular system, with cholesterol ... the false assumption that if cholesterol levels are good, this ...
(Date:5/23/2013)... (PRWEB) May 23, 2013 US ... 5.1 percent annually to $8.0 billion in 2017. ... the increasing need for high-performance plastic films that ... and chemical resistance in packaging and construction applications. ... market areas such as photovoltaic modules biodegradable products, ...
(Date:5/23/2013)... 23, 2013 Dr. Garber's Natural ... specific remedies are now available at Whole Foods Laguna ... 92677. The line of natural biotherapy formulas continues to ... , Represented by Brandstorm HBC (Los Angeles, CA), the ... throughout California, Nevada and Arizona, as well as Lassen's ...
(Date:5/23/2013)... York (PRWEB) May 23, 2013 Spring is ... Assisi Veterinary Hospital urges pet owners to be aware of ... treatments for pet allergies. , An allergy is a state ... called an allergen. Allergen exposure may cause an over-reaction. This ... against infection and disease, can actually be harmful to the ...
Breaking Medicine News(10 mins):Health News:Angelina Jolie has Women Asking for Ways to Reduce the Risk of Breast Cancer 2Health News:hCGTreatments / Diet Doc hCG Diets & Weight Loss Plans Offers Safe and Healthy New Fast Weight Loss Alternative for At-Risk Heart Disease Patients 2Health News:hCGTreatments / Diet Doc hCG Diets & Weight Loss Plans Offers Safe and Healthy New Fast Weight Loss Alternative for At-Risk Heart Disease Patients 3Health News:U.S. Specialty Films Market Worth $8 Billion & Packaging Drives Industry by 2017 Says New Research Report at ReportsnReports.com 2Health News:U.S. Specialty Films Market Worth $8 Billion & Packaging Drives Industry by 2017 Says New Research Report at ReportsnReports.com 3Health News:U.S. Specialty Films Market Worth $8 Billion & Packaging Drives Industry by 2017 Says New Research Report at ReportsnReports.com 4Health News:Dr. Garber's Natural Solutions Now Available at Whole Foods Market, Laguna Niguel, CA 2Health News:Allergy Season Affects Pets as Well as People 2
... sympathetic to people suffering from the same misfortune as a ... generally more sympathetic, according to the authors of a new ... A. Small and Uri Simonsohn (both University of Pennsylvania) seek ... become more sympathetic when a friend or loved one falls ...
... into the desire to have an attractive smile is ... immigrants are the most receptive to oral health messages, ... of Consumer Research . , Authors Shuili Du ... and C.B. Bhattacharya (Boston University) evaluated the effectiveness of ...
... The American Academy of Actuaries, Public Interest Committee ... market value of assets and liabilities for ... use information obtained through this forum ... board of directors on the issue is appropriately in the public ...
... 22 Republican National,Committee (RNC) Chairman Robert M. ... http://www.newscom.com/cgi-bin/prnh/20080519/RNCLOGO ), "While Barack Obama ... political tactics to push poor people away from ... is yet another example of,Obama,s rhetoric not matching ...
... --, NEW YORK, Aug. 22 The Guardian ... has hired industry veteran,Dale Magner to its leadership team. ... plan sales and distribution to his new post as,Vice ... August 12., Magner will be responsible for developing ...
... ST. LOUIS, Aug. 22 CMS, Inc., an ... and workflow management,solutions, has received FDA 510(k) clearance ... allows CMS to immediately,begin distributing Atlas-Based Autosegmentation for ... the amount of time spent creating and editing,patient ...
Cached Medicine News:Health News:Charities take note: Personal relationships increase donations 2Health News:A reason to smile: New immigrants respond best to oral hygiene campaign 2Health News:Actuaries to Host Forum on Public Pension Disclosures 2Health News:Actuaries to Host Forum on Public Pension Disclosures 3Health News:RNC Statement Obama and Health Care 2Health News:Dale Magner Joins Guardian as Vice President 2Health News:CMS, Inc., an Elekta Company, Receives FDA 510(k) Clearance for Atlas-Based Autosegmentation Software 2
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: